Clozapine optimization: a delphi consensus guideline from the treatment response and resistance in psychosis working group

E Wagner, D Siskind, P Falkai, O Howes… - Schizophrenia …, 2023 - academic.oup.com
Abstract Background and Hypothesis There is limited evidence to guide the approaches to
clozapine treatment. Accordingly, an international initiative was undertaken with the aim of …

A guideline and checklist for initiating and managing clozapine treatment in patients with treatment-resistant schizophrenia

CU Correll, O Agid, B Crespo-Facorro… - CNS drugs, 2022 - Springer
Abstract Treatment-resistant schizophrenia (TRS) will affect about one in three patients with
schizophrenia. Clozapine is the only treatment approved for TRS, and patients should be …

Association between clozapine plasma concentrations and treatment response: a systematic review, meta-analysis and individual participant data meta-analysis

F Tralongo, C Konecki, C Feliu, A Kaladjian… - Clinical …, 2023 - Springer
Abstract Background and Objectives Although therapeutic drug monitoring of clozapine is
recommended, its optimisation is often adjusted only on the basis of dosage. The aim of this …

Pharmacokinetics and pharmacogenomics of clozapine in an ancestrally diverse sample: a longitudinal analysis and genome-wide association study using UK clinical …

AF Pardiñas, DB Kappel, M Roberts, F Tipple… - The Lancet …, 2023 - thelancet.com
Background The antipsychotic, clozapine, is the only licensed drug against the treatment-
resistant symptoms that affect 20–30% of people with schizophrenia. Clozapine is markedly …

Optimising plasma clozapine levels to improve treatment response: an individual patient data meta-analysis and receiver operating characteristic curve analysis

K Northwood, E Pearson, U Arnautovska… - The British Journal of …, 2023 - cambridge.org
BackgroundAlthough clozapine is the most efficacious medication for treatment-refractory
schizophrenia, not all patients will have an adequate response. Optimising clozapine dose …

Effect of smoking habits and concomitant valproic acid use on relapse in patients with treatment‐resistant schizophrenia receiving clozapine: A 1‐year retrospective …

M Tsukahara, R So, Y Yoshimura… - Acta Psychiatrica …, 2023 - Wiley Online Library
Introduction No study has investigated the impact of smoking habits and concomitant
valproic acid (VPA) use on clinical outcomes in maintenance treatment with clozapine. Thus …

Third-generation antipsychotics in patients with schizophrenia and non-responsivity or intolerance to clozapine regimen: What is the evidence?

O Vasiliu - Frontiers in psychiatry, 2022 - frontiersin.org
Clozapine is considered «the golden standard» for the management of treatment-resistant
schizophrenia, but many patients do not present adequate responsivity even to this …

A systematic review of clozapine for aggression and violence in patients with schizophrenia or schizoaffective disorder

J Faden, L Citrome - Schizophrenia Research, 2024 - Elsevier
Although uncommon, the risk of aggression and violence is greater in people with
schizophrenia than in the general population. Clozapine is the “gold standard” …

Study on the daily dose and serum concentration of clozapine in psychiatric patients and possible influencing factors of serum concentration

T Liu, P Gao, C **e, H Zhang, Z Shi, R Chen - BMC psychiatry, 2023 - Springer
Background Clozapine is the most effective drug for treatment-resistant schizophrenia, and
the dosage and concentration of clozapine in the treatment of mental illness vary greatly in …

Impact of NFIB and CYP1A variants on clozapine serum concentration—A retrospective naturalistic cohort study on 526 patients with known smoking habits

HÇ Lenk, R Løvsletten Smith… - Clinical and …, 2023 - Wiley Online Library
Clinical response of clozapine is closely associated with serum concentration. Although
tobacco smoking is the key environmental factor underlying interindividual variability in …